All Penny Stocks.com News: Zoetis Buying Nexvet, Strengthens Dog and Cat Pain Drug Pipeline

Mississauga, ON -- (SBWire) -- 04/13/2017 --AllPennyStocks.com Media, Inc. (http://www.AllPennyStocks.com/) announces its latest article titled "Zoetis Buying Nexvet, Strengthens Dog and Cat Pain Drug Pipeline."

Companies mentioned in this article include Nexvet (NASDAQ:NVET) and Zoetis (NYSE:ZTS).

Article Excerpt:

Dogs and cats are people too. Okay, well maybe not, but they certainly are companions to millions of people that love them and don't want them to suffer from pain. Neither does Nexvet (NASDAQ:NVET), a developer of monoclonal antibody therapies for companion animals. The Ireland-based veterinary biologic therapeutics company's work has paid off for nearly every shareholder that bought in since May 2015, as Zoetis (NYSE:ZTS) today agreed to pay a premium to acquire the company.

Per the deal, which is being run through a Zoetis subsidiary, Nexvet will be acquired for $6.72 per share, or about $85 million in cash. That's a 65.93% premium to the closing price of NVET shares on Wednesday.

The full version of this article can be found at:
http://www.allpennystocks.com/aps_us/special-reports/744/zoetis-buying-nexvet-strengthens-dog-and-cat-pain-drug-pipeline.htm

About AllPennyStocks.com
AllPennyStocks.com is focused on the small-cap / penny stock market and has become a reputable name in the investment community. AllPennyStocks.com runs a Canadian and US site to provide investors in Canada as well as the United States with informative and unique content and information. AllPennyStocks.com runs daily technical penny stocks to watch, has a daily market write-up, provides company spotlights, runs unique most active pages strictly for penny stocks trading on the TSX, TSX Venture, NASDAQ and OTC BB, and much more information for the average investor.

AllPennyStocks.com also runs an email newsletter that aims to uncover stocks that are still under the radar of most investors. Criteria AllPennyStocks.com looks for includes strong revenues, a seasoned management, innovative business plans, among many others. AllPennyStocks.com also looks for companies that announce breaking news, recent 52-week highs/lows, technical breakouts, and other favorable corporate information.

Investors are encouraged to subscribe to the AllPennyStocks.com FREE e-mail newsletter and see what tens of thousands of other investors have already been receiving since 1999.

Investors can receive their free newsletter subscription by clicking here:
http://www.allpennystocks.com/aps_common/newsletter_free.asp

Contact:
AllPennyStocks.com Media, Inc.
Peter Szafranski -- President
Phone: 905-361-5680
E-Mail: peter@allpennystocks.com
Websites: http://www.allpennystocks.com / http://www.bullishinvestor.com

Note: AllPennyStocks.com has not received compensation for carrying the above-mentioned company; a full disclaimer can be viewed here: http://www.allpennystocks.com/aps_common/disclaimer.asp

Media Relations Contact

Peter Szafranski
905-361-5680
http://www.allpennystocks.com

View this press release online at: http://rwire.com/794496